Ginkgo Bioworks Holdings (DNA) Twitter Mentions Statistics 2025

113 13%

1W 22.8% 1M 6.6% 3M 44.1%

Est. daily mentions on Twitter.

Similar companies

Company		Twitter Mentions
	Amgen AMGN	16 50%
	Gilead Sciences GILD	73 82.5%
	Inovio Pharmaceuticals INO	24 71.4%
	Anavex Life Sciences AVXL	11 22.2%
	Crispr Therapeutics CRSP	13 30%

Month over Month

Est. daily mentions on Twitter.

Sep 2025	116	43.4%
Aug 2025	81	72.3%
Jul 2025	293	50.8%
Jun 2025	194	13.2%
May 2025	224

How often is DNA mentioned on X?

The cashtag $DNA was mentioned an estimated 113 times in X posts yesterday.

Analyzing Twitter Mentions, how is Ginkgo Bioworks Holdings performing compared to its industry peers?

Compared to its peers, Ginkgo Bioworks Holdings ranks in the 50th percentile when it comes to Twitter Mentions.

Why is it important to track Twitter mentions for Ginkgo Bioworks Holdings?

By monitoring Twitter mentions for Ginkgo Bioworks Holdings, investors gain real-time insights into public sentiment towards the company, its products, and its industry. Positive mentions may indicate growing interest, customer satisfaction, or emerging trends, while negative mentions can alert investors to potential issues, controversies, or market challenges. By tracking these mentions over time, investors can identify patterns, spot emerging trends, and make informed decisions based on the evolving sentiment and public perception of Ginkgo Bioworks Holdings, ultimately improving their investment strategies.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.